NSA 3/9/23 ED: Update in Medical Management of Heart Failure
Management of chronic heart failure (CHF) is becoming more nuanced and specific since the development of newer inpatient treatments like SGLT2, Ivabradine, and Entresto (used to treat CHF w/ reduced ejection fraction). There are also new updates in evidence based-inpatient treatments of heart failure with preserved EF and heart failure with reduced EF that out clinicians should be aware of. Furthermore, ,management of refractory right sided heart failure will be discussed to provide physicians withy tips on how to manage this difficult condition.
Inpatient evidence-based management of congestive heart failure with focus on newer therapies.
Napa/Solano Emergency and Internal Medicine Department physicians.
1. Inpatient treatment for heart failure with reduced EF particularly newer therapies including SGLT2, Ivabradine and Entresto (indications to start inpatient, what to watch for)
2. Evidence based inpatient treatment for heart failure with preserved EF and hoe it differs from heart failure with reduced EF
3. Briefly advanced refractory heart failure therapies and right-sided chronic heart failure and any therapies in addition to diuresis for EHF
Jeffrey Siu, DO, Emergency Department, Kaiser Permanente, Vacaville
Anjanet David, Kaiser Napa Solano Emergency Medicine Department, Senior Administrator
Navdeep Gupta MD, Hospital Based Medicine
Mandeep Jhutti, DO Hospital Based Medicine
Amir Axelrod, MD, Cardiology
The CME committee members, planners and reviewers of this activity have no relevant financial relationships with ineligible companies. The instructor/speaker(s) has no relevant financial relationship with ineligible companies. Kaiser Permanente Napa/Solano takes responsibility for the content, quality, and scientific integrity of this CME activity. Kaiser Permanente does not endorse any brand-name products.
Kaiser Napa/Solano is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. The Kaiser Napa/Solano designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
- 1.00 AMA PRA Category 1 Credit(s)™